Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey White

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
The New Zealand Medical Journal|April 3, 2010
Prasugrel, Māori, and personalised medicine in New ZealandPatrick Gladding, Harvey White, Mark Webster
European Heart Journal|May 28, 2014
Importance of frailty in patients with cardiovascular diseaseMandeep Singh, Ralph Stewart, Harvey White
American Journal of Veterinary Research|July 1, 1982
Method for determining serum pepsinogen concentration, using pepsin standards and ultraviolet absorbanceJ D Harvey-White, E H Allen
Clinical Pharmacology and Therapeutics|June 28, 2002
Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and genderRichard Robson, Harvey White, Philip Aylward, et al.
Life Sciences|January 1, 1988
Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administrationI J Kopin, K Bankiewicz, J Harvey-White
The New Zealand Medical Journal|March 12, 2026
Ethnic differences in population-level intracerebral haemorrhage incidence in Aotearoa New Zealand: findings from three Auckland Regional Community Stroke cohortsKarim M Mahawish, Valery Feigin, Harvey White, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1988
Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTPI J Kopin, K S Bankiewicz, J Harvey-White
Current Cardiology Reports|May 8, 2014
Universal MI definition update for cardiovascular diseaseHarvey White, Kristian Thygesen, Joseph S Alpert, et al.
European Journal of Pharmacology|April 13, 1988
The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey modelT Brücke, K Bankiewicz, J Harvey-White, et al.
The New Zealand Medical Journal|March 13, 2025
Refining predictive risk models for stroke in atrial fibrillation: a scoping review and meta-analysis for Aotearoa New Zealand, Māori and Pacific peoplesKarim M Mahawish, Harvey White, Valery Feigin, et al.
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
The New Zealand Medical Journal|April 3, 2010
Prasugrel, Māori, and personalised medicine in New ZealandPatrick Gladding, Harvey White, Mark Webster
European Heart Journal|May 28, 2014
Importance of frailty in patients with cardiovascular diseaseMandeep Singh, Ralph Stewart, Harvey White
American Journal of Veterinary Research|July 1, 1982
Method for determining serum pepsinogen concentration, using pepsin standards and ultraviolet absorbanceJ D Harvey-White, E H Allen
Clinical Pharmacology and Therapeutics|June 28, 2002
Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and genderRichard Robson, Harvey White, Philip Aylward, et al.
Life Sciences|January 1, 1988
Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administrationI J Kopin, K Bankiewicz, J Harvey-White
The New Zealand Medical Journal|March 12, 2026
Ethnic differences in population-level intracerebral haemorrhage incidence in Aotearoa New Zealand: findings from three Auckland Regional Community Stroke cohortsKarim M Mahawish, Valery Feigin, Harvey White, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1988
Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTPI J Kopin, K S Bankiewicz, J Harvey-White
Current Cardiology Reports|May 8, 2014
Universal MI definition update for cardiovascular diseaseHarvey White, Kristian Thygesen, Joseph S Alpert, et al.
European Journal of Pharmacology|April 13, 1988
The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey modelT Brücke, K Bankiewicz, J Harvey-White, et al.
The New Zealand Medical Journal|March 13, 2025
Refining predictive risk models for stroke in atrial fibrillation: a scoping review and meta-analysis for Aotearoa New Zealand, Māori and Pacific peoplesKarim M Mahawish, Harvey White, Valery Feigin, et al.
Pageof 20